Tuberculosis of kidney and ureter
ICD-10 A18.11 is a billable code used to indicate a diagnosis of tuberculosis of kidney and ureter.
Tuberculosis of the kidney and ureter is a rare but serious form of extrapulmonary tuberculosis that occurs when Mycobacterium tuberculosis infects the renal system. This condition can arise from hematogenous spread from a primary pulmonary infection or from direct extension from adjacent structures. Patients may present with nonspecific symptoms such as flank pain, hematuria, and renal colic. Diagnosis typically involves imaging studies such as ultrasound or CT scans, along with microbiological tests including urine cultures and PCR testing for Mycobacterium tuberculosis. Treatment usually consists of a multi-drug regimen including isoniazid, rifampin, pyrazinamide, and ethambutol, administered over a period of at least six months. Monitoring for drug resistance is crucial, as resistance can complicate treatment and prolong recovery. Public health implications are significant, as renal tuberculosis can be a marker for disseminated disease, necessitating contact tracing and isolation procedures in cases of active disease. Regular follow-up is essential to ensure treatment adherence and monitor for potential complications such as renal failure or abscess formation.
Detailed documentation of renal function tests, imaging studies, and treatment plans.
Patients presenting with renal pain, hematuria, or renal masses.
Consideration of renal function when prescribing anti-tuberculosis medications.
Comprehensive documentation of diagnostic criteria, treatment regimens, and follow-up care.
Patients with a history of tuberculosis presenting with renal symptoms.
Monitoring for drug resistance and potential interactions with other medications.
Used when renal biopsy is performed to confirm tuberculosis.
Pathology report and clinical notes indicating the need for biopsy.
Nephrology and Infectious Disease specialists should collaborate on biopsy interpretation.
Common symptoms include flank pain, hematuria, and renal colic. Patients may also experience systemic symptoms such as fever and weight loss.
Diagnosis typically involves imaging studies, urine cultures for Mycobacterium tuberculosis, and sometimes renal biopsy.
Treatment usually consists of a multi-drug regimen including isoniazid, rifampin, pyrazinamide, and ethambutol, monitored for adherence and drug resistance.
Contact tracing and isolation procedures may be necessary, especially in cases of active disease, to prevent transmission.
